CLINICAL USE OF THE NEWER ANTIPSYCHOTIC-DRUGS

Authors
Citation
Pj. Perry, CLINICAL USE OF THE NEWER ANTIPSYCHOTIC-DRUGS, American journal of health-system pharmacy, 52(3), 1995, pp. 9-14
Citations number
19
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
10792082
Volume
52
Issue
3
Year of publication
1995
Supplement
1
Pages
9 - 14
Database
ISI
SICI code
1079-2082(1995)52:3<9:CUOTNA>2.0.ZU;2-L
Abstract
The clinical use of clozapine and risperidone is reviewed. Traditional antipsychotic drugs are effective for treating the positive symptoms of schizophrenia but have little or no effect on the negative symptoms of this disease. Newer antipsychotic agents, such as clozapine and ri speridone, are effective for treating both positive and negative sympt oms in acutely ill and treatment-resistant patients. Clozapine and ris peridone also have a lower incidence of extrapyramidal symptoms (EPS) than traditional antipsychotic drugs.Three hypotheses have been propos ed to account for the newer agents' ability to relieve negative sympto ms: (1) Improvement in negative symptoms may be linked to improvement in positive symptoms. (2) Negative symptoms may improve in the absence of the EPS often caused by traditional agents. (3) The newer antipsyc hotic agents may directly affect the neural circuits that trigger nega tive symptoms.